NASDAQ:GILD - Gilead Sciences Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $69.20 -0.58 (-0.83 %) (As of 11/18/2018 04:00 PM ET)Previous Close$69.20Today's Range$68.93 - $69.7052-Week Range$64.27 - $89.54Volume7.96 million shsAverage Volume7.31 million shsMarket Capitalization$89.52 billionP/E Ratio8.08Dividend Yield3.29%Beta1.01 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Gilead Sciences (NASDAQ:GILD) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.19 Wall Street analysts have issued ratings and price targets for Gilead Sciences in the last 12 months. Their average twelve-month price target is $88.6250, suggesting that the stock has a possible upside of 28.07%. The high price target for GILD is $105.00 and the low price target for GILD is $72.00. There are currently 9 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.532.642.632.61Ratings Breakdown: 0 Sell Rating(s)9 Hold Rating(s)10 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)9 Hold Rating(s)12 Buy Rating(s)1 Strong Buy Rating(s)0 Sell Rating(s)10 Hold Rating(s)13 Buy Rating(s)1 Strong Buy Rating(s)0 Sell Rating(s)9 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $88.6250$88.1984$87.9414$88.1458Price Target Upside: 28.07% upside14.23% upside14.63% upside31.07% upsideGilead Sciences (NASDAQ:GILD) Consensus Price Target History Gilead Sciences (NASDAQ:GILD) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails11/14/2018OppenheimerReiterated RatingHoldMedium11/14/2018Needham & Company LLCReiterated RatingHoldMedium11/1/2018Raymond JamesReiterated RatingBuyLow11/1/2018MizuhoSet Price TargetBuy$94.00Medium10/31/2018Evercore ISIReiterated RatingBuyMedium10/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$90.00 ➝ $95.00Medium10/26/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$85.00 ➝ $75.00High10/26/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$87.00 ➝ $88.00Medium7/26/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$81.00 ➝ $85.00Medium7/26/2018Wells Fargo & CoBoost Price TargetOutperform$89.00 ➝ $95.00High7/26/2018Robert W. BairdDowngradeOutperform ➝ Neutral$79.00High5/2/2018Leerink SwannSet Price TargetMarket Perform$80.00 ➝ $72.00High4/17/2018Credit Suisse GroupSet Price TargetHold$80.00Low2/23/2018Royal Bank of CanadaReiterated RatingBuy$94.00Low2/8/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Market Perform$86.00 ➝ $88.00High2/8/2018CitigroupReiterated RatingBuy ➝ Buy$103.00 ➝ $105.00High2/7/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$82.00 ➝ $87.00Medium2/6/2018Maxim GroupSet Price TargetBuy$94.00High1/26/2018Jefferies Financial GroupUpgradeHold ➝ Buy$81.19 ➝ $93.00High11/13/2017ArgusDowngradeBuy ➝ Hold$73.25 ➝ $73.77N/A10/25/2017JPMorgan Chase & Co.Set Price TargetBuy$85.00N/A10/19/2017William BlairReiterated RatingBuyN/A10/19/2017Berenberg BankSet Price TargetBuy$96.00N/A10/5/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformN/A8/31/2017CowenReiterated RatingOutperform$90.00Medium8/31/2017Deutsche BankReiterated RatingBuy$81.00Medium7/26/2017Redburn PartnersInitiated CoverageBuyMedium5/3/2017GabelliReiterated RatingBuy$85.00Medium5/3/2017Stifel NicolausReiterated RatingBuy$87.00Medium3/13/2017Goldman Sachs GroupReiterated RatingNeutral$70.00 ➝ $68.00Low3/9/2017UBS GroupReiterated RatingNeutral ➝ Neutral$118.00 ➝ $72.00N/A(Data available from 11/18/2016 forward) This page was last updated on 11/18/2018 by MarketBeat.com StaffFeatured Article: What does the Dow Jones Industrial Average (DJIA) measure?